SCHEMBL3156154

SCHEMBL3156154

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCN(CCCc3ccccc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.63

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 3/20 0.63
▸ ADORA3 P0DMS8 1/20 0.63
▸ ADORA2A P29274 1/20 0.63
▸ ADORA1 P30542 1/20 0.63
▸ FAAH O00519 2/20 0.44
▸ HTR2A P28223 2/20 0.43
▸ HTR2C P28335 2/20 0.43
▸ HTR2B P41595 2/20 0.43
▸ SIGMAR1 Q99720 7/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3170151 0.95 ADORA2B (0.56) ADORA2BADORA3ADORA2AADORA1FAAH
SCHEMBL3162725 0.92 ADORA2B (0.53) ADORA2BADORA3ADORA2AADORA1HTR2A
SCHEMBL3167779 0.91 ADORA2B (0.52) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL3164833 0.90 ADORA2B (0.49) ADORA2BADORA3ADORA2AADORA1MEN1
SCHEMBL3165340 0.90 ADORA2B (0.49) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL3171345 0.90 ADORA2B (0.49) ADORA2BADORA3ADORA2AADORA1FAAH
SCHEMBL3171242 0.88 ADORA2A (0.48) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL3162838 0.88 ADORA3 (0.58) ADORA2BADORA3ADORA2AADORA1FAAH
SCHEMBL3173228 0.88 ADORA1 (0.47) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL3155892 0.88 ADORA2A (0.46) ADORA2BADORA3ADORA2AADORA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback